ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2600

Gender-Attributable Differences in Outcome of Ankylosing Spondylitis: Long-Term Results from the Outcome in Ankylosing Spondylitis International Study

Casper Webers1, Ivette Essers1,2, Sofia Ramiro3,4, Carmen Stolwijk1,2, Robert Landewé5, Désirée van der Heijde6, Filip van Den Bosch7, Maxime Dougados8,9 and Astrid van Tubergen1,10, 1Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 2School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, 3Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center/University of Amsterdam, Amsterdam, Netherlands, 4Rheumatology, Hospital Garcia de Orta, Almada, Portugal, 5Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 6Leiden University Medical Center, Leiden, Netherlands, 7Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium, 8Paris-Descartes University, Paris, France, 9Rheumatology, Hopital Cochin, Descartes University, Paris, France, 10Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose: In ankylosing spondylitis (AS), gender-attributable differences have been reported with respect to clinical and radiographic outcome. However, longitudinal studies exploring gender-attributable differences in the outcome of AS are scarce, and have limited follow-up. The aim of the present study was to investigate gender-attributable differences with respect to clinical outcomes (disease activity, function and quality of life (QoL)) and radiographic damage in patients with AS over time.

Methods: Clinical and radiological data from patients included in the Outcome in AS International Study (OASIS) were used. Disease activity was assessed by the Bath AS Disease Activity Index (BASDAI), the AS Disease Activity Score (ASDAS), and C-reactive protein (CRP); physical function by Bath AS Functional Index (BASFI); QoL by the Short Form-36 (SF-36), ASQoL and EuroQoL; radiographic damage by the modified Stoke AS Spine Score (mSASSS). First, cross-sectional comparative analyses were done at baseline. Second, separate models were created to assess gender-attributable differences on each outcome measure over time using time-adjusted generalized estimation equations (GEE). All analyses were performed in the total population and in those patients who completed the total 12 years of follow-up.  

Results: 216 patients (154 (72.3%) men, mean age 43.6 years (SD 12.7), symptom duration 20.5 years (SD 11.8), mean follow up duration 8.3 years (SD 4.1)) were included. At baseline, male compared with female patients had lower self-reported disease activity (BASDAI 3.2 vs. 3.9, p=0.03) but more radiographic damage (mSASSS 13.8 vs. 6.5, p=0.02). No significant differences in other clinical parameters between gender were found at baseline. In univariable analysis, a significant association between male gender and better QoL (lower ASQoL and higher EuroQoL), and between male gender and more radiographic damage (higher mSASSS) over time was found.

Also in multivariable analysis, male gender was, compared with female gender, significantly associated with a better ASQoL (B= -1.10, 95%CI -2.11 to -0.09, p=0.03), and in a separate multivariable analysis also with higher mSASSS over time (B=8.52, 95%CI 4.55 to 12.50, p<0.01). Similar results were found for the 12-year completers.

Conclusion: In this longstanding observational cohort study in patients with AS, no gender-attributable differences in disease activity and function over time were found. However, male gender, compared with female gender, was found to be associated with more radiographic damage, but also better QoL. It is likely that gender differences in AS are determined by both biological and psychological factors, and that male and female patients differ in the way they cope with pain and disability.


Disclosure:

C. Webers,
None;

I. Essers,
None;

S. Ramiro,
None;

C. Stolwijk,
None;

R. Landewé,
None;

D. van der Heijde,
None;

F. van Den Bosch,
None;

M. Dougados,
None;

A. van Tubergen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-attributable-differences-in-outcome-of-ankylosing-spondylitis-long-term-results-from-the-outcome-in-ankylosing-spondylitis-international-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology